Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000188775 | SCV000242399 | likely pathogenic | not provided | 2015-07-17 | criteria provided, single submitter | clinical testing | p.Gly324Ala (GGA> GCA): c.971 G>C in the PRRT2 gene (NM_145239.2) A G324A missense change likely associated with paroxysmal kinesigenic dyskinesia with infantile convulsions (PKD/IC) or benign familial infantile seizures (BFIS) was identified in the PRRT2 gene. It has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. However, two different amino acid substitutions at the same residue (G324R; G324E) have been previously reported in association with infantile convulsions and paroxysmal choreoathetosis and benign familial infantile seizures, respectively (Marini et al., 2012). G324A is a conservative amino acid substitution of one uncharged, non-polar amino acid for another; however, it alters a position that is highly conserved across species. Additionally, the G324A variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations, and multiple in silico models predict a damaging effect on the structure/function of the protein. Therefore, G324A is a strong candidate for a disease-causing mutation, however the possibility that it is a benign variant cannot be excluded. The variant is found in PRRT2 panel(s). |